HPV Testing A Cost-effective Strategy For Women With Equivocal Cervical Screening Results
Thu, 19 Jan 2006 02:00 PM EST
... A new study has found that using human papillomavirus (HPV) DNA testing to determine who should receive a cervical examination called colposcopy is a cost-effective management strategy for women with equivocal Pap test results known as ASCUS (atypical squamous cells of undetermined significance). The study appears in the January 18 issue of the Journal of the National Cancer Institute... click link for more info. ...
Related Topics
- Hpv
- Cervical Dysplasia
- Cervical Cancer
- Genetic Testing
- Neck Disorders and Injuries
- Screening
- Amniocentesis
- Colposcopy
- HIV Testing
- Prenatal Screening
- Cervical Stenosis
- Human Papilloma Virus
- Pku
- Women's Health
- Human Papilloma Virus (hpv)
- Prenatal Testing
- Biopsy
- Cervical Cerclage
- AFIX Immunization Strategy
- Electrodermal screening

Not Signed In -


